EDE Edenville

    Eden Research plc

Further Progress on Botrytis

Eden Research plc ("Eden") is pleased to announce that it has received a successful vinification
report with regard to the use of its compound 3AEY to treat botrytis on grapes.  A vinification
report assesses the amount of taint (if any) to the wine caused by any residues of the compounds
used to treat the disease.

As part of the previously announced agreement with Cheminova, Eden agreed to commission a separate
French vinification study.  Eden had already commissioned vinification studies in other
Mediterranean countries.  The French study has been concluded and a successful report has been
received by Eden.

This represents a small but significant milestone with regard to the Cheminova master agreement.

As a result of the receipt of this successful report Eden has now invoiced Cheminova for �100,000
being the agreed next stage payment.

The process of registration for 3AEY continues to timetable.


Tim Griffiths the Chief Executive Officer of Eden said:-

"Whilst we already we have received successful vinification reports for several other countries,
the French market is key and we did agree with our partners, Cheminova, that we would commission a
separate new study.  We are very pleased to have received a successful result.  Everything remains
on course for registration and we are looking forward to achieving the next milestone with our
partners Cheminova".

Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844

Matthew Robinson/Rose Herbert, FinnCap
T : 020 7600 1658

Jonathon Brill/Caroline Stewart, Financial Dynamics
T: 020 7831 3113


About Eden Research plc

Eden  Research  plc  is  a  UK  publicly listed company on the PLUS Market,  specialising  in  the
development  of  agrochemical products and intellectual property through licensing  and  marketing
agreements.

Eden  is  focused  on developing products for the agricultural sector through the  application  of
terpene  chemistry  and other patented environmentally friendly technologies.  Eden  is  currently
working  alongside universities and partner companies in developing its product portfolio  towards
commercialisation.

For further information please visit www.edenresearch.com.


                                                                
Eden Research plc



                                                                

Edenville (LSE:EDE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Edenville (LSE:EDE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024